ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder

Ryan Marino, Jeanmarie Perrone, Lewis S. Nelson, Timothy J. Wiegand, Evan S. Schwarz, Paul M. Wax, Andrew I. Stolbach

Research output: Contribution to journalArticlepeer-review

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)307-309
Number of pages3
JournalJournal of Medical Toxicology
Issue number4
StatePublished - Oct 1 2019


  • Buprenorphine
  • Opioid agonist therapy
  • Opioid use disorder
  • Waiver
  • X-waiver

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this